MedTrace Logo

Safety Study About the mRNA Vaccines Against COVID-19 in Children (PEDIVACOV-HCSC)

NCT06646744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2100

Last updated 2024-10-17

No results posted yet for this study

Summary

Drugs side effects in children need to be evaluated in a different way because of their constant growth and body changes.

The use of COVID-19 vaccines (mRNA vaccines) is worldwide spread as a safety measure against the pandemic.

Although clinical trials have shown that vaccines are safe in the general population, specific real-life monitoring is needed to address the special situation that applies to children.

Conditions

  • COVID-19 Vaccine Adverse Reaction

Interventions

BIOLOGICAL

mRNA COVID-19 vaccine

Children will be vaccinated according to standard local procedure

Sponsors & Collaborators

  • Ana Belen Rivas Paterna

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-08
Primary Completion
2023-03-03
Completion
2023-03-03

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06646744 on ClinicalTrials.gov